Evidence map›Paper›PMID 42599134›Full record

ArticleProceedings (Baylor University. Medical Center)2026

Preexisting cardiovascular disease and inpatient arrhythmias after autologous stem cell transplantation for multiple myeloma: a National Inpatient Sample analysis.

Hector Garcia Pleitez, Nehemias Guevara Rodriguez, Chanokporn Puchongmart, Dina Soliman, Andrea Ortiz Maldonado, Noemy Coreas, Jonathan Hernandez Munoz, Ben Thiravetyan, Sakditad Saowapa, Lukman Tijani and 1 more

Abstract read
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hector Garcia PleitezDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.ORCID 0009-0007-9711-7473
Nehemias Guevara RodriguezDivision of Hematology, Oncology, and Bone Marrow Transplant, Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA.
Chanokporn PuchongmartDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Dina SolimanDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Andrea Ortiz MaldonadoDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Noemy CoreasDivision of Gynecologic Oncology, University of El Salvador, Salvadoran Social Security Institute, San Salvador, El Salvador.
Jonathan Hernandez MunozDepartment of Internal Medicine, University of El Salvador, Salvadoran Social Security Institute, San Salvador, El Salvador.
Ben ThiravetyanDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Sakditad SaowapaDivision of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, Iowa, USA.
Lukman TijaniDepartment of Hematology-Oncology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Ranju KunworDivision of Hematology, Oncology, and Bone Marrow Transplant, Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutologous stem cell transplantation (ASCT) remains the standard for transplant-eligible multiple myeloma (MM) patients. However, data on inpatient arrhythmias among MM-ASCT hospitalizations with preexisting cardiovascular disease (CVD) remain limited. We evaluated present-on-admission (POA)-coded new-onset inpatient arrhythmias according to preexisting CVD status.

methodsWe analyzed the unweighted National Inpatient Sample (2016-2022) and identified adult MM-ASCT hospitalizations with valid POA indicators. Preexisting CVD included coronary artery disease, atrial fibrillation, valvular disease, conduction disorders, congestive heart failure, and prior cardiac arrest. The primary outcome was POA-coded new-onset inpatient arrhythmia. Secondary outcomes included length of stay, hospital charges, and discharge disposition. Firth's penalized logistic regression was used for sparse events, with LASSO regression performed as an exploratory sensitivity analysis.

resultsAmong 58 MM-ASCT hospitalizations, 12 (21%) had preexisting CVD. New-onset inpatient arrhythmias occurred in 9 hospitalizations (16%) and were more frequent with preexisting CVD (66.7% vs 2.2%,

conclusionsNew-onset inpatient arrhythmias were more frequent among MM-ASCT hospitalizations with preexisting CVD. These findings are hypothesis-generating and warrant validation in larger clinically adjudicated cohorts.

Indexed as

Arrhythmias, CardiacCardiovascular DiseasesHematopoietic Stem Cell TransplantationMultiple MyelomaAdultAgedFemaleHospitalizationHumansInpatientsLength of StayMaleMiddle AgedTransplantation, AutologousUnited StatesArrhythmiasautologous stem cell transplantationmultiple myelomapreexisting cardiovascular disease

Identifiers

PMID42599134
PMCPMC13689798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.